Healthy Village, Wealthy Life: How Investing in Public Health is Essential for the Lithium Supply Chain

In brief

• Hard-rock lithium operations in rural sub-Saharan Africa face a structural productivity drain that is rarely quantified: malaria alone generates up to eleven lost workdays per episode across a workforce where ten to fifteen percent of workers may be infected in any given year; HIV-related absenteeism, accelerated workforce turnover, and TB co-morbidity compound that loss into a standing operating cost that dwarfs the price of basic clinical infrastructure.

• The legal and financial liabilities that accrue from inadequate occupational health surveillance — silicosis compensation claims, dust-exposure litigation, insurance premium escalation, regulatory shutdown orders — are slow to materialise but fast to compound; South Africa's gold mining sector paid out ZAR 5 billion in a single 2019 class-action silicosis settlement whose underlying epidemiological failure was three decades in the making.

• A Health Premium model — embedding health investment as a contractual capital expenditure in mineral development agreements, governed by public data-sharing protocols, and linked to preferential development finance terms — converts a discretionary line item into a risk-managed asset class. 

The Supply Crunch Nobody Talks About

By 2035, the IEA projects that announced mine supply will cover roughly fifty percent of lithium demand under climate-aligned scenarios. The gap will be filled from the pegmatite belt — Zimbabwe, Mali, Ghana, the wider sub-Saharan hard-rock corridor. Zimbabwe alone saw output rise from 800 metric tonnes in 2022 to 22,000 in 2024. Africa's aggregate lithium production is projected to reach 497,000 tonnes by 2030, a twelvefold increase in seven years.

These deposits sit in some of the highest disease-burden environments on Earth. Sub-Saharan Africa accounts for 94 percent of global malaria mortality. HIV prevalence among working-age adults in Zimbabwe's major mining districts regularly exceeds ten percent. Tuberculosis incidence across southern Africa remains among the world's highest — and TB carries a documented synergistic relationship with silica dust exposure, the primary occupational hazard of hard-rock extraction. The regions the energy transition cannot do without are the regions least equipped, on current operational models, to absorb what extraction costs.

That is not a welfare argument. It is a supply chain stability argument.

What the Spreadsheet Gets Wrong

The standard treatment of community and workforce health in African mining finance is to place it under CSR, set a nominal annual budget, and manage to that floor. This is an accounting error.

In labour-constrained environments where skilled drillers, blasters, and processing-plant operators take months to recruit and years to develop, the productivity of the workforce is the primary input variable. Disease does not sit outside the production function but is central to it.

Malaria alone generates up to eleven lost workdays per episode in high-transmission settings. In Côte d'Ivoire, malaria has been found to account for 58 percent of total sick days among formal workers. The WHO's own modelling found that countries with heavy malaria endemicity experienced annual per-capita GDP growth of 0.4 percent between 1965 and 1990, against 2.3 percent for other countries — a structural drag that is, in any mining district that has not invested in prophylaxis and treatment infrastructure, fully in play. Add HIV-related absenteeism, presenteeism, and accelerated turnover, and the aggregate productivity cost at a 1,200-person lithium operation runs to thousands of working days per year before a single mine-specific occupational exposure is counted.

The Harvard meta-analysis on workplace health investment found that medical costs fall by USD 3.27 for every dollar invested in a comprehensive employee health programme, with absenteeism costs falling a further USD 2.73. These returns are from high-income country baselines. In rural sub-Saharan Africa, where baseline health status is more compromise, the marginal return on clinical intervention is correspondingly higher.

The Silica Time-Bomb

Hard-rock lithium is not brine lithium: Crushing and processing spodumene generates respirable crystalline silica (RCS) — the established cause of silicosis, COPD, lung cancer, and renal disease — at concentrations that, in a 2024 seven-year study of Western Australian operations, exceeded the regulatory standard of 0.05 mg/m³ among workers in crushing, processing, and maintenance roles. These are the roles that expanding African operations require in bulk.

In sub-Saharan Africa, RCS exposure does not operate in an epidemiological vacuum. Silica inhalation impairs the macrophage-mediated immune response that limits TB bacterial replication, producing a silico-tuberculosis co-presentation with a fatality rate substantially higher than either condition alone. In Zimbabwe's mining districts, where TB incidence is among the world's highest and HIV-TB co-infection is common, operating a silica-generating process without dust monitoring and clinical surveillance creates excess mortality risk in a population already at elevated baseline risk.

The latency of these infections is the trap. Silicosis typically presents clinically fifteen to twenty years after initial exposure at moderate concentrations. South Africa's gold sector provides the prospective view: ZAR 5 billion paid out in a 2019 class action involving 90,000 former mineworkers, with years of international press scrutiny, supply chain due diligence challenges, and management distraction compounding the direct settlement cost. The underlying failure was not exceptional negligence. It was the sustained treatment of occupational health as a compliance floor rather than an operating investment — and the absence of baseline surveillance records that made attribution both inevitable and impossible to contest.

A 2024 narrative review in the Journal of Occupational Medicine and Toxicology found that occupational and environmental exposure in the lithium mining sector presents significant risks of both acute and chronic toxicity, while simultaneously identifying a striking paucity of data specific to African lithium operations. That absence of data presents a silently accumulating liability.

What We Can Learn from the Zimbabwe Contrast

Zimbabwe is already running the experiment. Sinomine Resource Group's Bikita Minerals operation — the largest lithium producer in the country — sits at one end of the performance spectrum: documented water source depletion, absence of adequate PPE for subcontractor workforces flagged repeatedly by the Associated Mine Workers' Union of Zimbabwe, a fatal workplace injury, and a blasting incident in August 2025 that injured three children from the surrounding community. Health infrastructure provision: minimal.

Zhejiang Huayou Cobalt's Arcadia operation, east of Harare, sits at the other end. A USD 1 million mine clinic with emergency and maternity wards. Free quarterly health checks including cancer screening. Fourteen kilometres of tarred community roads. A USD 1.3 million CSR plan for 2025–2027. Community reception is cautiously positive; the Goromonzi District Development Inspector's office is formally engaged as a co-partner.

The gap between Arcadia and Bikita is not primarily a gap in corporate ethics, however. Huayou's downstream exposure runs to European and North American battery supply chains subject to the EU Battery Regulation's mandatory due diligence requirements — requirements that make documentable health and welfare performance a commercial necessity rather than a reputational option. Sinomine's primary downstream market faces lighter regulatory burden on these dimensions, at present.

The policy implication is direct: the health performance differential between these two operations is a function of where the regulatory signal sits in the supply chain.

The Data Asset Nobody Is Capturing

One underexamined dimension of mining health investment is its character as epidemiological infrastructure. In rural sub-Saharan Africa, the absence of baseline health data is among the most significant constraints on both public health response and the development of rational regulatory standards.

A mining operation running systematic occupational health surveillance — worker health records, dust monitoring, water quality testing, community disease incidence tracking — generates, at marginal additional cost, an epidemiological dataset of substantial value to at least three audiences.

For the operator, it provides the targeted intelligence necessary to identify which exposure pathways drive the highest health crises, enabling precision engineering controls rather than blanket expenditure.

For national health ministries, it provides baseline data currently absent from most rural mining districts — data that is the necessary precondition for evidence-based regulation.

For development finance institutions, it provides the impact documentation that justifies concessional co-financing of the health infrastructure that serves both the operation and the surrounding community.

The Objections, Answered

The attribution problem — that health improvements cannot be reliably linked to mining investment — is methodological, not structural. Baseline surveys can be conducted at margial cost with long-term operational and data benefits before first extraction. The absence of this approach from existing mining health programmes arguably reflects institutional inertia and not impossibility.

The competitive disadvantage argument — that health investors bear costs that non-investors avoid — is accurate under the current voluntary framework, and can be addressed by well-structured contracts: Mandatory covenants in mineral development agreements convert discretionary health investment into a level-playing-field requirement and,ultimately,a competitive edge.

The crowding-out risk — that mining health infrastructure allows governments to divert public funds away from mining districts — is real and is mitigated specifically by co-governance design of public health infrastructure in rural mining contexts. A facility co-signed by the Ministry of Health and tracked through the national health planning cycle is not a private substitute for public provision but can be an increment to it.

Conclusion

The IEA's 2025 projection of a 40 percent supply shortfall in lithium by 2035 under current project pipelines is a statement about extraction geography: the next decade of supply must come from rural Africa. The communities above those reserves seem set to, on current trajectories, absorb the occupational and environmental costs of that extraction while capturing little of its value — and the operations extracting it will accumulate liabilities that, when they crystallise, will cost more to resolve than the health investment would have cost to make.

The disease burden of rural sub-Saharan Africa is a manageable production variable rather than an immovable background condition. The return on managing it is positive, the forward liability of not managing it is large, and the data and finance infrastructure to do so exists. What is missing is the governance architecture to make it structurally unavoidable.

The communities above the lithium are not an obstacle to the green transition. They are an important condition of its durability.

George Katito is CEO/Founder of Geostratagem